Abiopharma

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026

Cellectis Announces 2026 Strategy and Catalysts

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

📋 Almstead Zheng Yang (Member of immediate family of any of the foregoing) plans to sell 59 shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $5K) Filed: Jan 08, 2026 | ID: 000225

New Form SCHEDULE 13D - IRIDEX CORP Filed: 2026-01-08 AccNo: 0002097627-26-000007 Size: 20 KB

📋 VanDuyn Amy Beth (Officer) plans to sell 3K shares of Phreesia, Inc. (at $17.01 each, total $44K) Filed: Jan 08, 2026 | ID: 000224

📋 Hoffman Allison C (Officer) plans to sell 7K shares of Phreesia, Inc. (at $17.01 each, total $112K) Filed: Jan 08, 2026 | ID: 000223

📋 Almstead Neil Gregory (Officer) plans to sell 881 shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $67K) Filed: Jan 08, 2026 | ID: 000222

📋 Lyssikatos Joseph P (Officer) plans to sell 82K shares of Enliven Therapeutics, Inc. (at $15.47 each, total $1.3M) Filed: Jan 08, 2026 | ID: 000005

📋 Heyman Richard A. (Director) plans to sell 2K shares of Enliven Therapeutics, Inc. (at $15.47 each, total $25K) Filed: Jan 08, 2026 | ID: 000004

📋 LAURA A WILLIAMS (Officer) plans to sell 50K shares of ARDELYX INC (at $5.83 each, total $292K) Filed: Jan 08, 2026 | ID: 000286

📋 JOSEPH OLIVETO (Director) plans to sell 80K shares of MILESTONE PHARMACEUTICALS INC (at $2.15 each, total $171K) Filed: Jan 08, 2026 | ID: 000282

📋 Pauwels Eric (Officer) plans to sell 1K shares of PTC THERAPEUTICS, INC. (at $76.45 each, total $111K) Filed: Jan 08, 2026 | ID: 000221

Director Cohen Steven Michael 🟡 adjusted position in 0 shares (1 derivative) of Tilray Brands, Inc. (TLRY) at $8.99 Transaction Date: Jan 07, 2026 | Filing ID: 000001